Patents by Inventor Eugene M. Laska

Eugene M. Laska has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5286751
    Abstract: Sustained and enhanced antipyretic response is elicited in a mammalian organism in need of such treatment, i.e., a mammal suffering from elevated body temperature (fever), by administering thereto a unit dosage sustainedly enhancing, antipyretically effective amount of the free acid S(+) flurbiprofen enantiomer, said enantiomer being substantially free of its R(-) flurbiprofen antipode.
    Type: Grant
    Filed: May 18, 1990
    Date of Patent: February 15, 1994
    Assignee: Analgesic Associates
    Inventors: Abraham Sunshine, Eugene M. Laska
  • Patent number: 5100918
    Abstract: Ultraviolet radiation induced erythema is prevented or treated in a human mammal in need of such prevention or treatment, i.e., a mammal suffering from or seeking to avoid sunburn, by topically administering thereto a unit dosage erythema-preventing or treating effective amount of the S(+) ibuprofen enantiomer, said enantiomer being substantially free of its R(-) ibuprofen antipode.
    Type: Grant
    Filed: October 5, 1990
    Date of Patent: March 31, 1992
    Assignee: Sterling Drug, Inc.
    Inventors: Abraham Sunshine, Eugene M. Laska
  • Patent number: 5025019
    Abstract: Pharmaceutical compositions and methods of using same comprising a non-steroidal anti-inflammatory drug in combination with at least one other active component selected from an antihistamine, decongestant, cough suppressant (antitussive) or expectorant are provided for the relief of cough, cold and cold-like symptoms.
    Type: Grant
    Filed: November 20, 1989
    Date of Patent: June 18, 1991
    Assignee: Analgesic Associates
    Inventors: Abraham Sunshine, Eugene M. Laska, Carole E. Siegel
  • Patent number: 4985459
    Abstract: Novel pharmaceutical compositions of matter are provided comprising analgesic/non-steroidal anti-inflammatory drugs and diphenhydramine and methods of using said compositions to elicit an enhanced analgesic and/or anti-inflammatory response in mammalian organisms in need of such treatment.
    Type: Grant
    Filed: October 13, 1989
    Date of Patent: January 15, 1991
    Assignee: Richardson-Vicks, Inc.
    Inventors: Abraham Sunshine, Eugene M. Laska, Carole E. Siegel
  • Patent number: 4980375
    Abstract: Onset-hastened and enhanced antipyretic response is elicited in a mammalian organism in need of such treatment, i.e., a mammal suffering from elevated body temperature (fever), by administering thereto a unit dosage onset-hastening/enhancing antipyretically effective amount of the S(+) ibuprofen enantiomer, said enantiomer being substantially free of its R(-) ibuprofen antipode.
    Type: Grant
    Filed: May 25, 1989
    Date of Patent: December 25, 1990
    Assignee: Sterling Drug Inc.
    Inventors: Abraham Sunshine, Eugene M. Laska
  • Patent number: 4975426
    Abstract: Pharmaceutical compositions and methods of using same comprising aspirin, sodium salicylate, salicylamide or acetaminophen, in combination with a non-sedating antihistamine and optionally one or more other active components selected from a decongestant, cough suppressant (antitussive) or expectorant are provided for the relief of cough, cold, cold-like and/or flu symptoms and the discomfort, pain, headache, fever and general malaise associated therewith.
    Type: Grant
    Filed: February 24, 1989
    Date of Patent: December 4, 1990
    Assignee: Analgesic Associates
    Inventors: Abraham Sunshine, Eugene M. Laska, Carole E. Siegel
  • Patent number: 4962124
    Abstract: Onset-hastened and enhanced antipyretic response is elicited in a human mammal in need of such treatment, i.e., a human mammal suffering from elevated body temperature (fever), by administering thereto a unit dosage onset-hastening/enhancing antipyretically effective amount of the S(+) ketoprofen enantiomer, said enantiomer being substantially free of its R(-) ketoprofen antipode.
    Type: Grant
    Filed: August 25, 1989
    Date of Patent: October 9, 1990
    Assignee: Analgesic Associates
    Inventors: Abraham Sunshine, Eugene M. Laska
  • Patent number: 4927854
    Abstract: Sustained and enhanced analgesic response is elicited in a mammalian organism in need of such treatment, i.e., a mammal suffering pain, by administering thereto a unit dosage sustainedly enhancing, analgesically effective amount of the free acid S(+) flurbiprofen enantiomer, said enantiomer being substantially free of its R(-) flurbiprofen antipode.
    Type: Grant
    Filed: July 21, 1989
    Date of Patent: May 22, 1990
    Assignee: Analgesic Associates
    Inventors: Abraham Sunshine, Eugene M. Laska
  • Patent number: 4923898
    Abstract: Novel pharmaceutical analgesic, anti-inflammatory and skeletal muscle relaxant compositions and methods of using same comprising an analgesically and anti-inflammatory effective amount of at least one non-steroidal anti-inflammatory drug other than aspirin, acetaminophen and phenacetin, in combination with an effective amount of a skeletal muscle relaxant.
    Type: Grant
    Filed: August 3, 1988
    Date of Patent: May 8, 1990
    Assignee: Analgesic Associates
    Inventors: Abraham Sunshine, Eugene M. Laska, Carole E. Siegel
  • Patent number: 4920149
    Abstract: Pharmaceutical compositions and methods of using same comprising a non-steroidal anti-inflammatory drug in combination with at least one other active component selected from an antihistamine, decongestant, cough suppressant (antitussive) or expectorant are provided for the relief of cough, cold and cold-like symptoms.
    Type: Grant
    Filed: January 15, 1988
    Date of Patent: April 24, 1990
    Assignee: Analgesic Associates
    Inventors: Abraham Sunshine, Eugene M. Laska, Carole E. Siegel
  • Patent number: 4906625
    Abstract: Novel pharmaceutical compositions of matter are provided comprising analgesic/non-steroidal anti-inflammatory drugs and diphenhydramine and methods of using said compositions to elicit and enhanced analgesic and/or anti-inflammatory response in mammalian organisms in need of such treatment.
    Type: Grant
    Filed: April 12, 1988
    Date of Patent: March 6, 1990
    Assignee: Richardson-Vicks, Inc.
    Inventors: Abraham Sunshine, Eugene M. Laska, Carole E. Siegel
  • Patent number: 4883818
    Abstract: Onset-hastened and enhanced analgesic response is elicited in a mammalian organism in need of such treatment, i.e., a mammal suffering pain, by administering thereto a unit dosage onset-hastening/enhancing analgesically effective amount of the S(+) fenoprofen enantiomer, said enantiomer being substantially free of its R(-) fenoprofen antipode.
    Type: Grant
    Filed: November 17, 1987
    Date of Patent: November 28, 1989
    Assignee: Analgesic Associates
    Inventors: Abraham Sunshine, Eugene M. Laska
  • Patent number: 4871733
    Abstract: Pharmaceutical compositions and methods of using same comprising a non-steroidal anti-inflammatory drug in combination with a non-sedating antihistamine and optionally one or more other active components selected from a decongestant, cough suppressant (antitussive) or expectorant are provided for the relief of cough, cold, cold-like and/or flu symptoms and the discomfort, pain, headache, fever and general malaise associated therewith.
    Type: Grant
    Filed: August 11, 1988
    Date of Patent: October 3, 1989
    Assignee: Analgesic Associates
    Inventors: Abraham Sunshine, Eugene M. Laska, Carole E. Siegel
  • Patent number: 4868214
    Abstract: Onset-hastened and enhanced analgesic response is elicited in a mammalian organism in need of such treatment, i.e., a mammal suffering pain, by administering thereto a unit dosage onset-hastening/enhancing analgesically effective amount of the S(+) ketoprofen enantiomer, said enantiomer being substantially free of its R(-) ketoprofen antipode.
    Type: Grant
    Filed: November 17, 1987
    Date of Patent: September 19, 1989
    Assignee: Analgesic Associates
    Inventors: Abraham Sunshine, Eugene M. Laska
  • Patent number: 4851444
    Abstract: Onset-hastened and enhanced analgesic response is elicited in a mammalian organism in need of such treatment, i.e., a mammal suffering pain, by administering thereto a unit dosage onset-hastening/enhancing analgesically effective amount of the S(+) ibuprofen enantiomer, said enantiomer being substantially free of its R(-) ibuprofen antipode.
    Type: Grant
    Filed: July 10, 1987
    Date of Patent: July 25, 1989
    Assignee: Analgesic Associates
    Inventors: Abraham Sunshine, Eugene M. Laska
  • Patent number: 4840962
    Abstract: Pharmaceutical compositions and methods of using same comprising a non-steroidal anti-inflammatory drug in combination with at least one other active component selected from an antihistamine, decongestant, cough suppressant (antitussive) or expectorant are provided for the relief of cough, cold and cold-like symptoms.
    Type: Grant
    Filed: March 22, 1988
    Date of Patent: June 20, 1989
    Assignee: Analgesic Associates
    Inventors: Abraham Sunshine, Eugene M. Laska, Carole E. Siegel
  • Patent number: 4839354
    Abstract: Pharmaceutical compositions and methods of using same comprising a non-steroidal anti-inflammatory drug in combination with at least one other active component selected from an anti-histamine, decongestant, cough suppressant (antitussive) or expectorant are provided for the relief of cough, cold and cold-like symptoms.
    Type: Grant
    Filed: February 19, 1987
    Date of Patent: June 13, 1989
    Assignee: Analgesic Associates
    Inventors: Abraham Sunshine, Eugene M. Laska, Carole E. Siegel
  • Patent number: 4829064
    Abstract: Pharmaceutical compositions and methods of using same comprising aspirin, sodium salicylate, salicylamide or acetaminophen, in combination with a non-sedating antihistamine and optionally one or more other active components selected from a decongestant, cough suppressant (antitussive) or expectorant are provided for the relief of cough, cold, cold-like and/or flu symptoms and the discomfort, pain, headache, fever and general malaise associated therewith.
    Type: Grant
    Filed: June 8, 1987
    Date of Patent: May 9, 1989
    Assignee: Analgesic Associates
    Inventors: Abraham Sunshine, Eugene M. Laska, Carole E. Siegel
  • Patent number: 4783465
    Abstract: Pharmaceutical compositions and methods of using same comprising a non-steroidal anti-inflammatory drug in combination with a non-sedating antihistamine and optionally one or more other active components selected from a decongestant, cough suppressant (antitussive) or expectorant are provided for the relief of cough, cold, cold-like and/or flu symptoms and the discomfort, pain, headache, fever and general malaise associated therewith.
    Type: Grant
    Filed: April 24, 1987
    Date of Patent: November 8, 1988
    Assignee: Analgesic Associates
    Inventors: Abraham Sunshine, Eugene M. Laska, Carole E. Siegel
  • Patent number: 4780463
    Abstract: Novel pharmaceutical analgesic, anti-inflammatory and skeletal muscle relaxant compositions and methods of using same comprising an analgesically and anti-inflammatory effective amount of at least one non-steroidal anti-inflammatory drug other than aspirin, acetaminophen and phenacetin, in combination with an effective amount of a skeletal muscle relaxant.
    Type: Grant
    Filed: October 30, 1987
    Date of Patent: October 25, 1988
    Assignee: Analgesic Associates
    Inventors: Abraham Sunshine, Eugene M. Laska, Carole E. Siegel